Marked Choroidal Thinning Observed after Intravitreal Brolucizumab Injection
Introduction: Here, we report a case of severe intraocular inflammation (IOI) and prominent choroidal thinning following the initial intravitreal brolucizumab injection (IVBr). Case Presentation: The patient was a 75-year-old Japanese man with type 2 age-related macular degeneration of both eyes. Un...
Furkejuvvon:
| Váldodahkkit: | , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Karger Publishers
2023-11-01
|
| Ráidu: | Case Reports in Ophthalmology |
| Fáttát: | |
| Liŋkkat: | https://beta.karger.com/Article/FullText/534817 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|